Informatics resources for tuberculosis - Towards drug discovery

被引:11
|
作者
Sundaramurthi, Jagadish Chandrabose [1 ]
Brindha, S. [2 ]
Reddy, T. B. K. [3 ]
Hanna, Luke Elizabeth [1 ]
机构
[1] TB Res Ctr ICMR, ICMR Biomed Informat Ctr, Madras 600031, Tamil Nadu, India
[2] Univ Madras, Dept Biochem, Madras 600025, Tamil Nadu, India
[3] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA
关键词
Tuberculosis; Bioinformatics; Cheminformatics; Database; Drug discovery; MYCOBACTERIUM-TUBERCULOSIS; METABOLIC PATHWAYS; WEB SITE; DATABASE; GENES; OPERONS; MICROBESONLINE; METACYC; DOCKING;
D O I
10.1016/j.tube.2011.08.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Integration of biological data on gene sequence, genome annotation, gene expression, metabolic pathways, protein structure, drug target prioritization and selection, has resulted in several online bioinformatics databases and tools for Mycobacterium tuberculosis. Alongside there has been a growth in the list of cheminformatics databases for small molecules and tools to facilitate drug discovery. In spite of these efforts there is a noticeable lag in the drug discovery process which is an urgent need in the case of emerging and re-emerging infectious diseases. For example, more than 25 online databases are available freely for tuberculosis and yet these resources have not been exploited optimally. Informatics-centered drug discovery based on the integration and analysis of both bioinformatics and cheminformatics data could fill in the gap and help to accelerate the process of drug discovery. This article aims to review the current standing of developments in tuberculosis-bioinformatics and highlight areas where integration of existing resources could lead to acceleration of drug discovery against tuberculosis. Such an approach could be adapted for other diseases as well. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 50 条
  • [21] Web resources facilitate drug discovery in treatment of COVID-19
    Mei, Long-Can
    Jin, Yin
    Wang, Zheng
    Hao, Ge-Fei
    Yang, Guang-Fu
    DRUG DISCOVERY TODAY, 2021, 26 (10) : 2358 - 2366
  • [22] Rare Diseases: Drug Discovery and Informatics Resource
    Mingzhu Zhao
    Dong-Qing Wei
    Interdisciplinary Sciences: Computational Life Sciences, 2018, 10 : 195 - 204
  • [23] Rare Diseases: Drug Discovery and Informatics Resource
    Zhao, Mingzhu
    Wei, Dong-Qing
    INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2018, 10 (01) : 195 - 204
  • [24] Computational resources in the management of antibiotic resistance: Speeding up drug discovery
    Maryam, Lubna
    Usmani, Salman Sadullah
    Raghava, Gajendra P. S.
    DRUG DISCOVERY TODAY, 2021, 26 (09) : 2138 - 2151
  • [25] GlyGen: Computational and Informatics Resources for Glycoscience
    York, William S.
    Mazumder, Raja
    Ranzinger, Rene
    Edwards, Nathan
    Kahsay, Robel
    Aoki-Kinoshita, Kiyoko F.
    Campbell, Matthew P.
    Cummings, Richard D.
    Feizi, Ten
    Martin, Maria
    Natale, Darren A.
    Packer, Nicolle H.
    Woods, Robert J.
    Agarwal, Gaurav
    Arpinar, Sena
    Bhat, Sanath
    Blake, Judith
    Castro, Leyla Jael Garcia
    Fochtman, Brian
    Gildersleeve, Jeffrey
    Goldman, Radoslav
    Holmes, Xavier
    Jain, Vinamra
    Kulkarni, Sujeet
    Mahadik, Rupali
    Mehta, Akul
    Mousavi, Reza
    Nakarakommula, Sandeep
    Navelkar, Rahi
    Pattabiraman, Nagarajan
    Pierce, Michael J.
    Ross, Karen
    Vasudev, Preethi
    Vora, Jeet
    Williamson, Tatiana
    Zhang, Wenjin
    GLYCOBIOLOGY, 2020, 30 (02) : 72 - 73
  • [26] Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection
    Quan, Yuan
    Xiong, Le
    Chen, Jing
    Zhang, Hong-Yu
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (03) : 616 - 621
  • [27] Open source drug discovery- A new paradigm of collaborative research in tuberculosis drug development
    Bhardwaj, Anshu
    Scaria, Vinod
    Raghava, Gajendra Pal Singh
    Lynn, Andrew Michael
    Chandra, Nagasuma
    Banerjee, Sulagna
    Raghunandanan, Muthukurussi V.
    Pandey, Vikas
    Taneja, Bhupesh
    Yadav, Jyoti
    Dash, Debasis
    Bhattacharya, Jaijit
    Misra, Amit
    Kumar, Anil
    Ramachandran, Srinivasan
    Thomas, Zakir
    Brahmachari, Samir K.
    TUBERCULOSIS, 2011, 91 (05) : 479 - 486
  • [28] Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis
    Swaminathan, Soumya
    Sundaramurthi, Jagadish Chandrabose
    Palaniappan, Alangudi Natarajan
    Narayanan, Sujatha
    TUBERCULOSIS, 2016, 101 : 31 - 40
  • [29] Peptide deformylase - a promising therapeutic target for tuberculosis and antibacterial drug discovery
    Sharma, Anshika
    Khuller, Gopal K.
    Sharma, Sadhna
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 753 - 765
  • [30] Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
    Hartkoorn, Ruben C.
    Sala, Claudia
    Neres, Joao
    Pojer, Florence
    Magnet, Sophie
    Mukherjee, Raju
    Uplekar, Swapna
    Boy-Roettger, Stefanie
    Altmann, Karl-Heinz
    Cole, Stewart T.
    EMBO MOLECULAR MEDICINE, 2012, 4 (10) : 1032 - 1042